A federal court in Virginia has ruled that restrictions imposed by the US drug regulator on the abortion pill mifepristone are “unlawful” and ordered the Trump administration to reconsider them.
The case was brought by the nonprofit Center for Reproductive Rights in May 2023 on behalf of abortion providers across Virginia, Kansas, and Montana.
At stake were a set of rules called Risk Evaluation and Mitigation Strategy (REMS) long decried by abortion advocates as unduly burdensome.
One forces prescribers to register with the manufacturer — creating a national database that advocates say could pose a safety risk for doctors.
Another requires pharmacies to be specially certified and maintain detailed records, and a third makes patients review counseling that critics called inaccurate.
In his ruling, entered Thursday but widely publicized on Friday, Judge Robert S. Ballou wrote that the new restrictions were “arbitrary and capricious” because “the FDA has steadfastly found,
This post was originally published on this site.
